LPCAT2 and metabolic dysfunction-associated steatotic liver disease: Up‐regulation of LPCAT2 in NAFLD may therefore be a potential driving force behind enrichment of AA in pericentral hepatocytes, enabling the phospholipid membrane to serve as a substrate pool for free AA and its eicosanoid metabolites.